TEVA PHARMACEUTICAL INDUSTRIES LIMITED Operating Lease, Liability, Noncurrent
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Operating Lease, Liability, Noncurrent of $282.00 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-07-29
- 2026-06-30: Operating Lease, Liability, Noncurrent $282.00M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $280.00M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $288.00M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $283.00M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $282.00M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $280.00M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $288.00M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $283.00M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $296.00M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $288.00M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $296.00M 10-K · filed 2026-02-03 |
| 2024-09-30 | $295.00M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $281.00M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $294.00M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $320.00M 10-K · filed 2025-02-05 |
| 2023-09-30 | $324.00M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $338.00M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $345.00M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $349.00M 10-K · filed 2024-02-12 |
| 2022-09-30 | $354.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $371.00M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $393.00M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $416.00M 10-K · filed 2023-02-10 |
| 2021-09-30 | $425.00M 10-Q · filed 2021-10-27 |
| 2021-06-30 | $444.00M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $441.00M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $479.00M 10-K · filed 2022-02-09 |
| 2020-09-30 | $472.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $414.00M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $411.00M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $435.00M 10-K · filed 2021-02-10 |
| 2019-09-30 | $394.00M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $426.00M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $424.00M 10-Q · filed 2019-05-02 |